Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study of E7386 in Combination With Other Anticancer Drug(s) in Subjects With Solid Tumors

NCT04008797 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT04008797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04008797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study of E7386 in Combination With Other Anticancer Drug(s) in Subjects With Solid Tumors
Lead sponsor
Eisai Inc.
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
July 11, 2019
Completion date
March 31, 2027
Enrollment
301 (estimated)
Sites
106

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, hepatocellular, colorectal neoplasms, endometrial neoplasms, liver neoplasms, neoplasms